Study of A-101 for the Treatment of Seborrheic Keratosis

NCT02260180 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
119
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.